Seven Eight Capital LP Buys New Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Seven Eight Capital LP purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 24,254 shares of the company’s stock, valued at approximately $1,555,000.

Several other hedge funds have also bought and sold shares of HSIC. Swedbank AB purchased a new position in Henry Schein during the 1st quarter valued at approximately $215,998,000. Norges Bank bought a new position in shares of Henry Schein during the 4th quarter valued at approximately $111,715,000. Thompson Siegel & Walmsley LLC purchased a new position in shares of Henry Schein in the second quarter valued at $46,683,000. Nuance Investments LLC increased its position in Henry Schein by 28.5% in the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock worth $132,552,000 after purchasing an additional 388,843 shares during the last quarter. Finally, Fiduciary Management Inc. WI raised its stake in Henry Schein by 17.1% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock valued at $172,947,000 after purchasing an additional 333,855 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.14% of the stock is owned by insiders.

Henry Schein Stock Up 0.1 %

Shares of HSIC opened at $72.54 on Friday. The firm has a fifty day moving average price of $69.77 and a 200-day moving average price of $70.42. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $9.29 billion, a P/E ratio of 24.51, a P/E/G ratio of 1.88 and a beta of 0.86. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm’s quarterly revenue was up .0% on a year-over-year basis. During the same period in the previous year, the company earned $1.31 EPS. Equities research analysts expect that Henry Schein, Inc. will post 4.75 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Robert W. Baird reduced their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Barrington Research decreased their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Piper Sandler reiterated an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. JPMorgan Chase & Co. decreased their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Finally, Evercore ISI dropped their price objective on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $77.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.